ALNY – alnylam pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge [Yahoo! Finance]
Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at Freedom Capital from a "hold" rating to a "strong-buy" rating.
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $510.00 price target on the stock.
Form 4 ALNYLAM PHARMACEUTICALS, For: Feb 23 Filed by: Fitzgerald Kevin Joseph
Form 4 ALNYLAM PHARMACEUTICALS, For: Feb 12 Filed by: Garg Pushkal
Form 4 ALNYLAM PHARMACEUTICALS, For: Feb 12 Filed by: Greenstreet Yvonne
Form 4 ALNYLAM PHARMACEUTICALS, For: Feb 12 Filed by: Fitzgerald Kevin Joseph
Form 4 ALNYLAM PHARMACEUTICALS, For: Feb 12 Filed by: Tanguler Tolga
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.